Does OMALIZUMAB Cause Lymphadenopathy? 279 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 279 reports of Lymphadenopathy have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.4% of all adverse event reports for OMALIZUMAB.
279
Reports of Lymphadenopathy with OMALIZUMAB
0.4%
of all OMALIZUMAB reports
3
Deaths
85
Hospitalizations
How Dangerous Is Lymphadenopathy From OMALIZUMAB?
Of the 279 reports, 3 (1.1%) resulted in death, 85 (30.5%) required hospitalization, and 14 (5.0%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
Yes, Lymphadenopathy is listed as a known adverse reaction in the official FDA drug label for OMALIZUMAB.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which OMALIZUMAB Alternatives Have Lower Lymphadenopathy Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS